title: [Use of eptifibatide in patients with acute stent thrombosis, requiring urgent surgical revascularisation - report of 2 cases].
abstract: Number of patients requiring intensive antiaggregation therapy in diseases of circulatory system is increasing. Simultaneously many patients are referred to CABG. In the article, based on two case reports, we discuss optimal time frame for performing cardiac surgery, methods to analyze platelet inhibition, and we describe technique of bridging by eptifibatide.
authors.affiliation: Oddział Kardiochirurgii, Slaski Uniwersytet Medyczny, Katowice.
authors.forename: Mirosław
authors.initials: M
authors.lastname: Wilczyński
authors.forename: Tomasz
authors.initials: T
authors.lastname: Bochenek
authors.forename: Joanna
authors.initials: J
authors.lastname: Góral
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Knast
authors.forename: Rafik
authors.initials: R
authors.lastname: Abu Samra
authors.forename: Krystian
authors.initials: K
authors.lastname: Wita
authors.forename: Andrzej
authors.initials: A
authors.lastname: Bochenek
mesh_terms: D054058:Acute Coronary Syndrome / Q000628:therapy; D001026:Coronary Artery Bypass; D003328:Coronary Thrombosis / Q000188:drug therapy* / Q000209:etiology / Q000601:surgery*; D000077542:Eptifibatide; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy; D009204:Myocardial Revascularization; D010455:Peptides / Q000008:administration & dosage*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D015607:Stents / Q000009:adverse effects*
chemical_list: D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide